SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                   FORM 10-QSB



                [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR
                  15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
                    For the quarter Ended September 30, 2000

                                       or

                  [ ] TRANSITION REPORT PURSUANT TO SECTION 13
                OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934


                         Commission File Number 0-28097


                              DOCTORSURF.COM, INC.
        (Exact name of small business issuer as specified in its charter)


        STATE OF FLORIDA                                  59-3569844
        ----------------                                  ----------
 (State or other jurisdiction of                         (IRS Employer
 incorporation or organization)                        Identification No.)


            6925 112th Circle North, Suite 101, Largo, Florida 33773
            --------------------------------------------------------
               (Address of principal executive offices)   (Zip Code)


         Issuer's telephone number, including area code: (727) 546-6476


Indicate by check mark whether the issuer (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. [X] Yes [ ] No

The number of shares outstanding of the Issuer's common stock at $.01 par value
as of December 29, 2000 was 23,585,000.


<PAGE>


                         PART I - FINANCIAL INFORMATION

                   Item 1. CONSOLIDATED FINANCIAL STATEMENTS.

                       DOCTORSURF.COM, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
                      CONDENSED CONSOLIDATED BALANCE SHEETS


<TABLE>
<CAPTION>
                                                               September 30,          December 31,
                                                                  2000                    1999
                                                            ------------------      ---------------
                                                               (Unaudited)            (Audited)

<S>                                                         <C>                     <C>
ASSETS

Current assets:
     Cash and cash equivalents                              $         494,916       $      658,629
     Accounts receivable, net                                           4,000                    -
     Due from related parties                                          27,250                    -
     Prepaid and other assets                                          15,249               86,121
                                                            ------------------      ---------------
Total current assets                                                  541,415              744,750

Property and equipment, net                                           126,629               82,023

Intangible assets, net                                                    117                    -
                                                            ------------------      ---------------

Total assets                                                 $        668,161        $     826,773
                                                            ==================      ===============


LIABILITIES AND STOCKHOLDERS' DEFICIENCY

Current liabilities:
     Accounts payable                                       $         274,279       $      174,417
     Accrued expenses                                                  14,935               87,353
     Other payables                                                   137,006                    -
     Current portion of long-term obligations                          18,667               25,417
     Common stock subject to rescission offer -
       $.01 par value, 750,000 shares issued
       and outstanding                                                      -              750,000
     Subscription receivable                                                -              (45,000)
     Obligation to potential stockholder                                    -               25,000
                                                            ------------------      ---------------
Total current liabilities                                             444,887            1,017,187
                                                            ------------------      ---------------

Long-term obligations, less current portion                           247,646               35,949

Minority interest                                                     328,610                    -

Commitments and contingencies

Stockholders' deficiency:
     Preferred stock, $.01 par value; 5,000,000
       shares authorized; no preferred shares
       issued or outstanding                                                -                    -
     Common stock, $.01 par value; 95,000,000
       shares authorized; 23,585,000 and
       22,500,000 shares issued and outstanding                       235,850              225,000
     Additional paid-in capital                                     1,193,062              166,000
     Deficit accumulated during the development stage              (1,781,894)            (617,363)
                                                            ------------------      ---------------
Total stockholders' deficiency                                       (352,982)            (226,363)
                                                            ------------------      ---------------

Total liabilities and stockholders' deficiency              $         668,161       $      826,773
                                                            ==================      ===============
</TABLE>



     See accompanying notes to condensed consolidated financial statements.






                                     - 2 -
<PAGE>


                       DOCTORSURF.COM, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
           CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (UNAUDITED)


<TABLE>
<CAPTION>
                                                                                                         For The Period
                                                                                                        From May 14, 1999
                                                 Three Months Ended         Nine Months Ended          (Date Of Inception)
                                                    September 30,             September 30,           Through September 30,
                                                        2000                       2000                       2000
                                               ------------------------   -----------------------   --------------------------

<S>                                             <C>                       <C>                        <C>
Operating expenses:
     Sales and marketing                        $                5,398    $              135,183     $                170,325
     General and administrative                                469,535                 1,102,578                    1,695,107
     Depreciation and amortization                              12,211                    30,005                       34,299
                                               ------------------------   -----------------------   --------------------------
Total operating expenses                                       487,144                 1,267,766                    1,899,731
                                               ------------------------   -----------------------   --------------------------


Other (income) expense:
     Interest income                                            (5,745)                  (19,940)                     (36,566)
     Other (income) expense                                     66,348                    57,428                       56,527
     Interest expense                                            9,285                    15,612                       18,536
                                               ------------------------   -----------------------   --------------------------
Total other income                                              69,888                    53,100                       38,497
                                               ------------------------   -----------------------   --------------------------

Loss attributable to minority interest                         (41,227)                 (156,334)                    (156,334)
                                               ------------------------   -----------------------   --------------------------

Net loss                                        $             (515,805)   $           (1,164,532)    $             (1,781,894)
                                               ========================   =======================   ==========================


Basic and diluted net loss per share            $                (0.02)   $                (0.05)    $                  (0.08)
                                               ========================   =======================   ==========================

Basic and diluted weighted average number
     of common shares outstanding                           22,825,598                22,632,828                   22,571,785
                                               ========================   =======================   ==========================
</TABLE>



















     See accompanying notes to condensed consolidated financial statements.





                                     - 3 -
<PAGE>


                       DOCTORSURF.COM, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
           CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED)

<TABLE>
<CAPTION>
                                                                                       For The Period
                                                                                      From May 14, 1999
                                                                Nine Months Ended    (Date Of Inception)
                                                                 September 30,       Through September 30,
                                                                     2000                   2000
                                                               ------------------    --------------------

<S>                                                            <C>                   <C>
 Cash flows from operating activities:
     Net loss                                                  $      (1,164,532)    $      (1,781,894)

     Adjustments to reconcile net loss to net
     cash used in operating activities:
        Depreciation and amortization                                     30,005                34,299
        Minority interest                                                328,610               328,610
        Contributed services                                              44,950               210,950
        Issuance of common stock for services                            460,000               460,000
        Changes in operating assets and liabilities:
           Increase in accounts receivable                                (4,000)               (4,000)
           (Increase) decrease in prepaid and other assets                70,732               (15,389)
           Increase in due from related parties                          (27,250)              (27,250)
           (Increase) decrease in accounts payable                      (100,138)              274,279
           Increase (decrease) in accrued expenses                       (72,418)               14,935
           Increase in other payables                                     12,006                12,006
                                                               ------------------    --------------------
Net cash used in operating activities                                   (422,035)             (493,454)
                                                               ------------------    --------------------

Cash flows from investing activities -
     Purchases of property and equipment                                 (74,587)             (107,784)
                                                               ------------------    --------------------

Cash flows from financing activities:
     Repayment of long-term obligations                                  (20,053)              (37,628)
     Repayment of obligation to potential stockholder                    (25,000)                    -
     Payment for common stock rescinded                                  (35,000)                    -
     Repayment of other payables                                        (250,000)             (250,000)
     Refund due to stockholder                                                 -                     -
     Proceeds from issuance of long-term obligations                     225,000               250,820
     Proceeds from issuance of other payables                            375,000               375,000
     Proceeds from issuance of common stock                               17,962               757,962
     Proceeds from issuance of common stock subject
       to rescission offer                                                35,000                     -
     Proceeds from subscription receivable                                10,000                     -
                                                               ------------------    --------------------
Net cash provided by financing activities                                332,909             1,096,154
                                                               ------------------    --------------------


Net increase in cash and cash equivalents                               (163,713)              494,916

Cash and cash equivalents, beginning of period                           658,629                     -
                                                               ------------------    --------------------

Cash and cash equivalents, end of period                       $         494,916     $          494,916
                                                               ==================    ====================


Supplemental disclosures of cash flow information:
     Cash paid during the period for interest                  $          11,765     $            14,689
                                                               ==================    ====================
     Cash paid during the period for income taxes              $               -     $                 -
                                                               ==================    ====================

Supplemental disclosures of noncash investing and
  financing activities:
     Issuance of common stock for subscription receivable      $               -     $            45,000
                                                               ==================    ====================
     Cancellation of common stock issued for subscription
        receivable                                             $          35,000     $            35,000
                                                               ==================    ====================
     Long-term obligation for capital lease incurred for
        purchase of property and equipment                     $               -     $            53,121
                                                               ==================    ====================
     Short-term obligation incurred for prepaid insurance
        policy                                                 $               -     $            25,820
                                                               ==================    ====================
</TABLE>




     See accompanying notes to condensed consolidated financial statements.





                                     - 4 -
<PAGE>


                       DOCTORSURF.COM, INC. AND SUBSIDIARY
                          (A DEVELOPMENT STAGE COMPANY)
        Notes To Condensed Consolidated Financial Statements (Unaudited)
          For the Three Months and Nine Months Ended September 30, 2000

NOTE A-BASIS OF PRESENTATION

         The accompanying condensed consolidated financial statements include
the accounts of DoctorSurf.com, Inc. and its subsidiary Emc911.com, Inc.
(collectively the "Company").   All intercompany balances and transactions have
been eliminated.

         On January 27, 2000, the Company formed Emc911.com, Inc. ("Emc911"), as
a Florida corporation, to engage in the business of development and marketing of
an emergency medical card. During the nine months ended September 30, 2000,
2,000,000 shares of common stock, $.001 par value, of Emc911 were issued to the
Company upon the incorporation of Emc911 and 2,000,000 shares of common stock
were sold to investors at $.25 per share for gross proceeds of $500,000. As of
September 30, 2000, there were 4,000,000 shares of common stock of Emc911 issued
and outstanding, of which the Company owned 2,000,000 shares.

         The accompanying unaudited condensed consolidated financial statements
have been prepared in accordance with generally accepted accounting principles
for interim financial information and with the instruction to Form 10-QSB and
Article 10 of Regulation S-X. Accordingly, they do not include all of the
information and footnotes required by generally accepted accounting principles
for complete financial statements. In the opinion of management, all adjustments
(consisting of normal recurring accruals) considered necessary for a fair
presentation have been included. Operating results for the three month and nine
month periods ended September 30, 2000 are not necessarily indicative of the
results that may be expected for the year ending December 31, 2000. For further
information, refer to the financial statements and footnotes included in the
Company's Form 10-KSB for the period from May 14, 1999 (date of inception) to
December 31, 1999.

         The accompanying condensed consolidated financial statements have been
prepared assuming that the Company will continue as a going concern. As
reflected in the consolidated financial statements, the Company is a development
stage enterprise, which has yet to generate revenues to support further
operations. Certain shareholders of the Company have contributed their personal
services to the Company. The value of these services for the nine month period
ended September 30, 2000 has been estimated to be $44,950 and has been recorded
as compensation expense in the accompanying condensed consolidated statement of
operations. In order to fund operations to date, the Company has relied on
funding raised from sales of the Company's equity securities. The Company has
incurred operating losses since inception and the contingency surrounding equity
shares issued as part of the Private Placement Memorandum (see Note D) raises
substantial doubt about its ability to continue as a going concern.

NOTE B-RESTRICTED CASH HELD IN ESCROW

 On April 24, 2000, the Company issued a Confidential Private Placement
Memorandum for the sale of up to 4,000,000 shares of its series A convertible
preferred stock at $2.50 per share, with minimum






                                      - 5 -
<PAGE>


proceeds of $500,000. In May and June 2000, a total of $250,000 was received
from investors and was deposited into escrow with First Community Bank of
America in St. Petersburg, Florida. Due to market conditions, the Company
withdrew the offering under the private placement and subsequently returned all
of the money collected in escrow.

NOTE C-RELATED PARTY TRANSACTIONS

         In July 2000, the Company received two notes receivable with principal
totaling $27,250 from two stockholders in EMC911.com, Inc. ("EMC") for the
purchase of 109,000 shares of $.001 par value common stock of EMC. The notes are
secured by the shares of stock of EMC. Interest on the notes is payable at a
rate of 6% per annum on the unpaid principal, with principal and unpaid interest
being payable no later than the sale of other disposition of the shares issued
in conjunction with the notes. The notes may be prepaid in whole or in part at
any time without penalty.

NOTE D-INCOME TAXES

         The Company has adopted Statement of Financial Accounting Standards No.
109 ("SFAS 109"), Accounting for Income Taxes. Under SFAS 109, the Company uses
the asset and liability method which recognizes the amount of current and
deferred taxes payable or refundable at the date of the financial statements as
a result of all events that have been recognized in the financial statements and
as measured by the provisions of enacted tax laws.

         The Company has a gross deferred tax asset as of September 30, 2000
that is comprised of the potential future tax benefit of its operating losses to
date. Management has evaluated the available evidence regarding the future
taxable income and other possible sources of realization of deferred tax assets.
A 100 percent valuation allowance has been established by management against the
gross deferred tax asset as it is more likely than not that the deferred tax
asset will not be realized.

NOTE E-COMMITMENTS

         Pursuant to a Private Placement Memorandum dated June 1999 (the
"Placement"), the Company offered 750,000 shares of the Company's common stock
for $1 per share. As of December 31, 1999, all of the 750,000 shares offered had
been sold. Due to a possible violation of the Securities Act of 1933
requirements, the Company has issued a memorandum to the purchasers of the
shares enabling them to sell their shares back to the Company at any time
through August 25, 2000 for the original issuance price of $1. As such, the
proceeds from the issuance of the 750,000 shares of common stock have been
classified outside of equity in the accompanying condensed consolidated balance
sheet as of December 31, 1999, under the caption Common Stock Subject to
Rescission Offer. During January 2000, two investors who had requested refunds
for shares purchased in conjunction with the Placement were paid $35,000 for
their 35,000 shares. These shares were subsequently reissued to new investors
for $1 per share. As of the date of this Report, nine additional investors with
a total of 125,000 shares had opted to rescind for a total amount of $125,000.
The Company is not in a position to pay cash to these investors and has
therefore recorded a liability under the caption other payables for the $125,000
due to these investors.

         The Company leases approximately 1,800 square feet of office space for
its executive offices and its operations in Largo, Florida. The facility is
located at 6925 112th Circle North, Suite 101, Largo,






                                      - 6 -
<PAGE>


Florida, 33773. The lease expired on August 31, 2000 and was renewed at the
option of the Company for an additional one-year term. The monthly lease
payments are $1,200, plus applicable sales tax. In January 2000, the Company
entered into a lease addendum agreeing to lease an additional 1,100 square feet.
The additional monthly rental payment is $350. In addition, the commencement
date of the original lease was changed to February 1, 2000. This new lease is
renewable at the option of the Company for an additional two-year term.

NOTE F-SIGNIFICANT EVENTS

         On March 7, 2000, the Company's registration statement on Form SB-2
Post-Effective Amendment No. 2 was declared effective by the Securities and
Exchange Commission (the "SEC"). However, because the Company is located in
Florida, the Florida blue sky laws require the Company to register as an
issuer/dealer with the Florida Division of Securities before it offers
securities to residents of Florida or any other state. Upon approval from the
Florida Division of Securities, the Company will be allowed to issue the
25,000,000 shares of common stock registered pursuant to the Form SB-2 in the
states of Florida, California, Louisiana, and Georgia. The Company intends to
apply for approval under the securities laws of the states not listed above.
Pursuant to the Company's marketing plan, these registered shares will be issued
at no cost to doctors who become secured members on the Company's web site. The
fair market value of these shares will be charged to operations as promotion
costs at the time of their issuance.

NOTE G-EARNINGS (LOSS) PER SHARE

         Basic and diluted net loss per common share is computed by dividing
loss available to common stockholders by the weighted-average number of common
shares outstanding during the period.























                                      - 7 -
<PAGE>


Item 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
         AND RESULTS OF OPERATIONS.

Overview

         The Company was formed to provide a premier Internet web site for
physicians and dentists (collectively "doctors") that will be dedicated to
doctor education, that will provide communication and information exchange using
state of the art technology and security, doctor authentication and a
combination of Internet protocols. Since its incorporation, the Company
primarily has focused on organizing activities and the development of its web
site.
         The Company is a development stage company and has not generated any
revenue since its inception on May 14, 1999 through September 30, 2000. In order
to fund its operations through September 30, 2000, the Company has relied on
funding raised from sales of the Company's equity securities.

         The Company develops, designs, programs and hosts an Internet web site
for doctors. The Company's web site address is www.DoctorSurf.com. The Company
web site became fully operational prior to March 31, 2000.

         Operating expenses include sales and marketing costs, general and
administrative costs and depreciation and amortization expense. Other income
(expense) consists primarily of interest income associated with cash maintained
in a money market fund and interest expense associated with borrowings to
finance capital equipment expenditures and other working capital needs.

Results of Operations

         Sales and marketing expenses. Sales and marketing expenses consist
primarily of advertising and promotional expenses. Sales and marketing expenses
were $5,398 and $135,183 for the three months and nine months ended September
30, 2000, respectively.

         General and administrative expenses. General and administrative
expenses consist primarily of personnel costs related to general management
functions, finance, accounting, payroll expenses and professional fees related
to legal, audit and tax matters, and web site hosting and update expenses.
General and administrative expenses were $469,535 and $1,102,578 for the three
months and nine months ended September 30, 2000, respectively.

         Interest income (expense), net. Interest expense, net of interest
income was $3,540 for the three months ended September 30, 2000. Interest
income, net of interest expense was $4,328 for the nine months ended September
30, 2000.

         Income taxes. The Company has no income tax provision for the periods
presented due to its net operating loss. The net operating loss may be carried
forward for up to 20 years. As such, the Company does not anticipate any
liability for income taxes for the fiscal year ended December 31, 2000. See Note
B to the condensed consolidated financial statements.






                                      - 8 -
<PAGE>


         Management believes that there was no material effect on operations or
the financial condition of the Company as a result of inflation in the three
months and nine months ended September 30, 2000.

Liquidity and Capital Resources

         The Company has financed its operations through the sale of equity
securities issued by the Company. The Company had working capital of $96,528 at
September 30, 2000. The Company estimates that it will need additional funds for
on-going web site development, marketing, promotions, and for general working
capital purposes over the next 12 months.

         Net cash used in operating activities was $422,035 for the nine months
ended September 30, 2000. The usage of cash attributable to the net operating
loss as well as an increase in accounts receivable of $4,000, an increase in due
from related parties of $27,250, a decrease in accounts payable of $100,138 and
a decrease in accrued expenses of $72,418, partially offset by an increase in
minority interest of $328,610, an increase in contributed services of $44,950,
an increase in issuance of common stock for services of $460,000, a decrease in
prepaid and other assets of $70,732 and an increase in other payables of
$12,006. During the nine months ended September 30, 2000 the Company was in its
development stage and did not generate any revenues. During 2000, management
expects that the Company will generate revenues through advertising and
sponsorships, and fees and commissions on transactions and sales occurring
through its web site, which will have future positive cash effects in its
operating activities.

         Net cash used in investing activities was $74,587 during the nine
months ended September 30, 2000, representing the purchase of property and
equipment.

         Net cash provided by financing activities was $332,909 during the nine
months ended September 30, 2000, representing proceeds from issuance of
long-term obligations of $225,000, proceeds from the issuance of other payables
of $375,000, proceeds from issuance of common stock of $17,962, proceeds from
the issuance of common stock subject to a rescission offer of $35,000 and
proceeds from a subscription receivable of $10,000, partially offset by
repayments of long-term obligations of $20,053, repayment of an obligation to a
potential stockholder of $25,000, payment for common stock rescinded of $35,000
and repayment of other payables of $250,000.

         From June through August 1999, 750,000 shares of common stock of the
Company were sold to accredited investors at $1.00 per share, for gross proceeds
of $750,000. Proceeds were used for general working capital purposes. The shares
were sold to a limited number of investors in a private placement that was not
registered under the federal securities laws. For federal securities law
purposes, however, the private placement and the free share offering may be
considered a single offering. If considered a single offering, the exemption
from registration that the Company relied on in making the private placement
would not be available and the private placement would not be exempt from
registration under the federal securities laws. Because of that possibility, the
Company has offered to each investor in the private placement the right to
resell their shares to the Company and receive a refund of the price paid by
them of $1 per share.

         The private placement investors' right to sell their shares to the
Company began on August 14, 1999 and will expire on August 25, 2000. As of June
30, 2000, two investors accepted the Company's offer to resell their shares and
received a refund of the purchase price. If all purchasers in the private





                                      - 9 -
<PAGE>


placement accept the Company's offer, the Company could have a potential
liability of $750,000. If this were to occur, the Company cannot be certain that
the Company would have sufficient funds to repurchase the shares that were sold
in the private placement. As of August 25, 2000 nine additional investors with a
total of 125,000 shares had opted to rescind for a total amount of $125,000. The
Company is not in a position to pay cash to these investors and has therefore
recorded a liability under the caption other payables for the $125,000 due to
these investors.

         In July 2000, the Company received two notes receivable with principal
totaling $27,250 from two stockholders in EMC911.com, Inc. ("EMC") for the
purchase of 109,000 shares of $.001 par value common stock of EMC. The notes are
secured by the shares of stock of EMC. Interest on the notes is payable at a
rate of 6% per annum on the unpaid principal, with principal and unpaid interest
being payable no later than the sale of other disposition of the shares issued
in conjunction with the notes. The notes may be prepaid in whole or in part at
any time without penalty.

         The Company's condensed consolidated financial statements have been
prepared assuming that it will continue as a going concern. The Company's losses
from operations since its inception raise substantial doubt as to its ability to
continue as a going concern.

         The Company leases approximately 1,800 square feet of office space for
its executive offices and its operations in Largo, Florida. The facility is
located at 6925 112th Circle North, Suite 101, Largo, Florida, 33773. The lease
expired on August 31, 2000 and was renewable at the option of the Company for an
additional one-year term. The monthly lease payments are $1,200, plus applicable
sales tax. On January 20, 2000, the Company entered into a lease addendum
agreeing to lease an additional 1,100 square feet. The additional monthly rental
payment is $350. In addition, the commencement date of the original lease was
changed to February 1, 2000. This new lease is renewable at the option of the
Company for an additional two-year term.

         Management believes that cash expected to be generated from operations,
current cash reserves, and existing financial arrangements will not be
sufficient for the Company to meet its capital expenditures and working capital
needs for its operations as presently conducted. The Company's future liquidity
and cash requirements will depend on a wide range of factors, including expected
results from operations as revenues are generated.

         The Company does not expect cash flows from operations to be sufficient
in the next twelve months. The Company is presently being funded through
borrowings from several of its shareholders and is in the process of discussions
with financial institutions for additional borrowings. The Company is also
considering raising capital either through a private placement or an initial
public offering. There can be no assurance that additional borrowings and/or
such capital would be raised in sufficient amounts to meet the Company's
financial needs in the next twelve months. Currently, if the shareholders
discontinue their funding, the Company may have to cease operations.








                                     - 10 -
<PAGE>


                           PART II - OTHER INFORMATION

Item 1. LEGAL PROCEEDINGS.

         From time to time, the Company may become involved in litigation
arising in the ordinary course of its business. The Company is not presently
subject to any material legal proceedings.

Item 2. CHANGES IN SECURITIES AND USE OF PROCEEDS.

         None.

Item 3. DEFAULTS UPON SENIOR SECURITIES.

         Not applicable.

Item 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

         Not applicable.

Item 5. OTHER INFORMATION.

         On March 7, 2000, the Company's registration statement on Form SB-2
Post-Effective Amendment No. 2 was declared effective by the Securities and
Exchange Commission (the "SEC"). However, because the Company is located in
Florida, the Florida blue sky laws require the Company to register as an
issuer/dealer with the Florida Division of Securities before it offers
securities to residents of Florida or any other state. Upon approval from the
Florida Division of Securities, the Company will be allowed to issue the
25,000,000 shares of common stock registered pursuant to the Form SB-2 in the
states of Florida, California, Louisiana, and Georgia. The Company intends to
apply for approval under the blue sky laws of the states not listed above.

         Pursuant to the Company's marketing plan, these registered shares will
be issued at no cost to doctors who become secured members on the Company's web
site. The fair market value of these shares will be charged to operations as
promotion costs at the time of their issuance. Doctors may become members and
participate fully in the web site even if they do not wish to receive shares in
the free stock offering.

Item 6. EXHIBITS AND REPORTS ON FORM 8-K.

(a) Exhibits.

         The following exhibits are filed with this report:

10.1     Lease Addendum between Pinellas Center For The Visually Impaired, Inc.
         and DoctorSurf.com, Inc. dated January 20, 2000.(1)

23.1     List of Subsidiaries. (2)






                                     - 11 -
<PAGE>


27.1     Financial Data Schedule (for SEC use only).

-------

         (1)  Incorporated by reference to the Company's Annual Report on Form
              10-KSB for the year ended December 31, 1999.

         (2)  Incorporated by reference to the Company's Quarterly Report on
              Form 10-QSB for the quarter ended March 31, 2000.

 (b) Reports on Form 8-K.

         During the three months ended September 30, 2000, the Company filed no
reports on Form 8-K.



                                   SIGNATURES

In accordance with the requirements of the Exchange Act, the registrant caused
this report to be signed on its behalf by the undersigned, thereunto duly
authorized.




                                       DoctorSurf.com, Inc.


Date:  January 2, 2001                 By: /s/Dr. Rakesh Sharma
                                          ---------------------
                                       Dr. Rakesh Sharma
                                       President and Director


















                                      - 12-